RA CAPITAL MANAGEMENT, L.P. Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$6.6T
Holdings
82
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (82 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A/S | 6,412,228 | $826.4B | 12.46% | |
| 2 | NVV1NOVAVAX INC | 3,002,087 | $544.3B | 8.21% | |
| 3 | VORVOR BIOPHARMA INC | 11,120,973 | $479.3B | 7.23% | |
| 4 | AVIRATEA PHARMACEUTICALS INC | 5,368,451 | $331.5B | 5.00% | |
| 5 | —FORMA THERAPEUTICS HLDGS INC | 9,011,651 | $252.5B | 3.81% | |
| 6 | TGTXTG THERAPEUTICS INC | 4,636,146 | $223.5B | 3.37% | |
| 7 | NKTXNKARTA INC | 5,605,129 | $184.4B | 2.78% | |
| 8 | CCXIEURCHEMOCENTRYX INC | 3,556,810 | $182.3B | 2.75% | |
| 9 | MGNXMACROGENICS INC | 4,933,594 | $157.1B | 2.37% | |
| 10 | 5E7ITEOS THERAPEUTICS INC | 4,417,258 | $151.0B | 2.28% | |
| 11 | IMGNEURIMMUNOGEN INC | 18,417,458 | $149.2B | 2.25% | |
| 12 | TVTXTRAVERE THERAPEUTICS INC | 5,614,428 | $140.2B | 2.11% | |
| 13 | TILINSTIL BIO INC | 4,870,793 | $122.2B | 1.84% | |
| 14 | PHATPHATHOM PHARMACEUTICALS INC | 3,115,008 | $117.0B | 1.76% | |
| 15 | ETNBGBP89BIO INC | 4,736,214 | $112.2B | 1.69% | |
| 16 | —KINNATE BIOPHARMA INC | 3,593,052 | $112.0B | 1.69% | |
| 17 | RYTMRHYTHM PHARMACEUTICALS INC | 4,871,067 | $103.6B | 1.56% | |
| 18 | —ZOGENIX INC | 5,283,976 | $103.1B | 1.56% | |
| 19 | AXSMAXSOME THERAPEUTICS INC | 1,655,447 | $93.7B | 1.41% | |
| 20 | RCKTROCKET PHARMACEUTICALS INC COM | 2,107,149 | $93.5B | 1.41% | |
| 21 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 9,365,833 | $92.3B | 1.39% | |
| 22 | EWTXEDGEWISE THERAPEUTICS INC | 2,613,623 | $84.9B | 1.28% | |
| 23 | —CURIS INC | 7,140,091 | $80.8B | 1.22% | |
| 24 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 2,378,325 | $78.3B | 1.18% | |
| 25 | PCVXVAXCYTE INC | 3,865,808 | $76.3B | 1.15% | |
| 26 | MCRB1EURSERES THERAPEUTICS INC | 3,694,193 | $76.1B | 1.15% | |
| 27 | SPRYSILVERBACK THERAPEUTICS INC | 1,742,186 | $76.0B | 1.15% | |
| 28 | 1K0IGM BIOSCIENCES INC | 982,723 | $75.4B | 1.14% | |
| 29 | KALAKALA PHARMACEUTICALS INC | 10,874,613 | $73.3B | 1.11% | |
| 30 | OLMAOLEMA PHARMACEUTICALS INC | 2,150,404 | $71.3B | 1.08% | |
| 31 | ORTXUSDORCHARD THERAPEUTICS PLC | 12,315,213 | $69.2B | 1.04% | |
| 32 | SLDBSOLID BIOSCIENCES INC | 12,367,873 | $68.4B | 1.03% | |
| 33 | DSGNDESIGN THERAPEUTICS INC | 2,186,636 | $65.4B | 0.99% | |
| 34 | BDTXBLACK DIAMOND THERAPEUTICS INC | 2,589,904 | $62.8B | 0.95% | |
| 35 | TREURTRILLIUM THERAPEUTICS INC | 5,290,481 | $56.8B | 0.86% | |
| 36 | PMVPPMV PHARMACEUTICALS INC | 1,710,265 | $56.3B | 0.85% | |
| 37 | CNTBCONNECT BIOPHARMA HLDGS LTD | 2,991,208 | $55.3B | 0.83% | |
| 38 | —CONSTELLATION PHARMCETICLS INC | 2,238,536 | $52.4B | 0.79% | |
| 39 | CCCCC4 THERAPEUTICS INC | 1,377,569 | $51.0B | 0.77% | |
| 40 | STROSUTRO BIOPHARMA INC | 2,118,212 | $48.2B | 0.73% | |
| 41 | GONGERON CORP | 30,126,299 | $47.6B | 0.72% | |
| 42 | WVEWAVE LIFE SCIENCES LTD | 7,775,207 | $43.6B | 0.66% | |
| 43 | DYNDYNE THERAPEUTICS INC | 2,805,045 | $43.6B | 0.66% | |
| 44 | VRNAVERONA PHARMA PLC | 5,100,000 | $42.6B | 0.64% | |
| 45 | ARDXARDELYX INC | 6,077,294 | $40.2B | 0.61% | |
| 46 | INZYINOZYME PHARMA INC | 2,003,653 | $39.7B | 0.60% | |
| 47 | —SATSUMA PHARMACEUTICALS INC | 5,914,252 | $35.0B | 0.53% | |
| 48 | RLAYRELAY THERAPEUTICS INC | 1,000,000 | $34.6B | 0.52% | |
| 49 | —AKOUOS INC | 2,281,249 | $31.6B | 0.48% | |
| 50 | CERE1EURCEREVEL THERAPEUTICS HLDNG INC | 2,200,000 | $30.2B | 0.46% | |
| 51 | CTMXCYTOMX THERAPEUTICS INC | 3,500,000 | $27.1B | 0.41% | |
| 52 | 698ACHILLES THERAPEUTICS PLC | 1,388,888 | $23.0B | 0.35% | |
| 53 | SNDXSYNDAX PHARMACEUTICALS INC | 1,023,067 | $22.9B | 0.34% | |
| 54 | LRMRLARIMAR THERAPEUTICS INC | 1,515,151 | $22.1B | 0.33% | |
| 55 | —IKENA ONCOLOGY INC | 750,000 | $21.2B | 0.32% | |
| 56 | SCPHSCPHARMACEUTICALS INC | 2,731,170 | $18.2B | 0.27% | |
| 57 | CNCEEURCONCERT PHARMACEUTICALS INC | 3,033,603 | $15.1B | 0.23% | |
| 58 | CGEMCULLINAN ONCOLOGY INC COM | 350,000 | $14.6B | 0.22% | |
| 59 | ORICORIC PHARMACEUTICALS INC | 584,000 | $14.3B | 0.22% | |
| 60 | PRQRPROQR THERAPEUTICS N V | 2,117,669 | $14.0B | 0.21% | |
| 61 | —BCTG ACQUISITION CORP | 1,250,000 | $13.9B | 0.21% | |
| 62 | —ARYA SCIENCES ACQUISITION CO | 971,430 | $13.4B | 0.20% | |
| 63 | —BCLS ACQUISITION CORP | 1,250,000 | $13.2B | 0.20% | |
| 64 | MISTMILESTONE PHARMACEUTICALS INC | 2,246,503 | $13.0B | 0.20% | |
| 65 | EYPTEYEPOINT PHARMACEUTICALS INC | 1,250,000 | $12.7B | 0.19% | |
| 66 | RPTXREPARE THERAPEUTICS INC | 409,000 | $12.6B | 0.19% | |
| 67 | OCULOCULAR THERAPEUTIX INC | 750,000 | $12.3B | 0.19% | |
| 68 | —ARYA SCIENCES ACQU CORP IV | 1,000,000 | $10.5B | 0.16% | |
| 69 | —THERAPEUTICSMD INC | 7,812,500 | $10.5B | 0.16% | |
| 70 | —FRAZIER LIFESCIENCES ACQUISITION CO | 1,000,000 | $10.2B | 0.15% | |
| 71 | —FS DEVELOPMENT CORP II | 1,000,000 | $10.0B | 0.15% | |
| 72 | —PHASEBIO PHARMACEUTICALS INC | 2,850,000 | $9.9B | 0.15% | |
| 73 | COGTCOGENT BIOSCIENCES INC | 1,025,641 | $9.0B | 0.14% | |
| 74 | KALVKALVISTA PHARMACEUTICALS INC | 350,000 | $9.0B | 0.14% | |
| 75 | —5 01 ACQUISITION CORP | 750,000 | $7.5B | 0.11% | |
| 76 | MLTXHELIX ACQUISITION CORP | 700,000 | $7.1B | 0.11% | |
| 77 | —HEALTH SCIENCES ACQ CORP 2 | 625,000 | $7.0B | 0.11% | |
| 78 | —SYROS PHARMACEUTICALS INC | 900,000 | $6.7B | 0.10% | |
| 79 | VRDNVIRIDIAN THERAPEUTICS INC | 312,328 | $5.2B | 0.08% | |
| 80 | ASNSUSDX4 PHARMACEUTICALS INC | 536,962 | $4.6B | 0.07% | |
| 81 | —IMARA INC | 248,804 | $2.1B | 0.03% | |
| 82 | —CEREVEL THERAPEUTICS HLDNG INC | 233,333 | $1.0B | 0.02% |